| Log in

Sun Pharma settles litigation with Novartis to launch generic drug in US

15 May, 2014

Sun Pharmaceutical Industries Ltd, the country’s largest drugmaker by market capitalisation, has signed a settlement agreement with international drug major Novartis Pharmaceuticals Corporation to launch a generic drug in the US, the company informed the stock exchange on Thursday.

“Under the terms of the agreement, Sun Pharma’s subsidiary may launch its version of generic Gleevec in the US on February 1, 2016,” the announcement said.

The Mumbai-based drug major had applied in 2007 for marketing approval for generic imatinib mesylate tablets, which is sold by Novartis as Gleevec. India has denied patent to Novartis for this drug in 2006. It is used for treatment of chronic myeloid leukemia.

According to the release, Sun Pharma could launch the generic copy of the drug in the US in February 2016 subject to regulatory approvals.  

The other terms of the agreement are confidential, the company said in the release.

At present, Sun Pharma holds a tentative approval from US FDA for its ANDA for a generic version of Gleevec. The drug has sales of around $2 billion in US, according to IMS.

“The deal has put clarity on the launch of the product and would fully reflect in the FY2017 financials. On a conservative basis, the product can contribute around $250 million and $75 million on sales and net profit, respectively, for the six-month exclusivity period,” said Sarabjit Kour Nangra, VP-Research, Pharma at Angel Broking.

(Edited by Joby Puthuparampil Johnson)


Leave Your Comment
Exclusive: Torrent Pharma buying select products of Novartis in India

Exclusive: Torrent Pharma buying select products of Novartis in India

Joseph Rai 9 months ago
Ahmedabad-based drugmaker Torrent Pharmaceuticals Ltd has agreed to acquire some...
Sun Pharma to acquire 14 Novartis brands in Japan for $293M

Sun Pharma to acquire 14 Novartis brands in Japan for $293M

Joseph Rai 2 years ago
Sun Pharmaceutical Industries Ltd will acquire 14 prescription brands from Swiss...
Sun Pharma to sell seven prescription brands to RPG Life Sciences

Sun Pharma to sell seven prescription brands to RPG Life Sciences

Joseph Rai 1 year ago
Sun Pharmaceutical Industries Ltd, India’s biggest drugmaker, said on...
No Comments

Sun Pharma settles litigation with Novartis to launch generic drug in US

Powered by WordPress.com VIP